Show simple item record

dc.contributor.authorDaniel, E
dc.contributor.authorAylwin, S
dc.contributor.authorMustafa, O
dc.contributor.authorBall, S
dc.contributor.authorMunir, A
dc.contributor.authorBoelaert, K
dc.contributor.authorChortis, V
dc.contributor.authorCuthbertson, D
dc.contributor.authorDaousi, C
dc.contributor.authorRajeev, S
dc.contributor.authorDavis, J
dc.contributor.authorCheer, K
dc.contributor.authorDrake, W
dc.contributor.authorGunganah, K
dc.contributor.authorGrossman, A
dc.contributor.authorGurnell, M
dc.contributor.authorPowlson, A
dc.contributor.authorKaravitaki, N
dc.contributor.authorHuguet, I
dc.contributor.authorKearney, T
dc.contributor.authorMohit, K
dc.contributor.authorMeeran, K
dc.contributor.authorHill, N
dc.contributor.authorRees, A
dc.contributor.authorLansdown, A
dc.contributor.authorTrainer, Peter J
dc.contributor.authorMinder, Anna-Elisabeth H
dc.contributor.authorNewell-Price, J
dc.date.accessioned2015-10-26T10:44:56Zen
dc.date.available2015-10-26T10:44:56Zen
dc.date.issued2015-09-09en
dc.identifier.citationEffectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients. 2015: 20152616 J Clin Endocrinol Metaben
dc.identifier.issn1945-7197en
dc.identifier.pmid26353009en
dc.identifier.doi10.1210/jc.2015-2616en
dc.identifier.urihttp://hdl.handle.net/10541/581084en
dc.description.abstractCushing's syndrome is a severe condition with excess mortality and significant morbidity necessitating control of hypercortisolemia. There are few data documenting use of the steroidogenesis inhibitor metyrapone for this purpose.
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen
dc.titleEffectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients.en
dc.typeArticleen
dc.contributor.departmentThe Medical School, University of Sheffield, Sheffield.en
dc.identifier.journalThe Journal of Clinical Endocrinology and Metabolismen
html.description.abstractCushing's syndrome is a severe condition with excess mortality and significant morbidity necessitating control of hypercortisolemia. There are few data documenting use of the steroidogenesis inhibitor metyrapone for this purpose.


This item appears in the following Collection(s)

Show simple item record